Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses
Clinical trial NCT02276963 · COMPLETED
Trial details
- NCT number
- NCT02276963
- Sponsor
- Johns Hopkins University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2017-07-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.